Reusable laryngoscope blades: a more eco-responsible and cost-effective alternative.

Carbon footprint Economic evaluation Life cycle assessment Medical waste Reusable device Sustainability

Journal

Anaesthesia, critical care & pain medicine
ISSN: 2352-5568
Titre abrégé: Anaesth Crit Care Pain Med
Pays: France
ID NLM: 101652401

Informations de publication

Date de publication:
10 2023
Historique:
received: 02 02 2023
revised: 20 06 2023
accepted: 24 06 2023
medline: 25 9 2023
pubmed: 13 7 2023
entrez: 12 7 2023
Statut: ppublish

Résumé

Consumption of single-use medical devices has increased considerably, contributing to the excessive wastage produced during surgical procedures. The present study aimed to describe a methodology to assess the transition from single-use blades (SUB) to reusable laryngoscope blades (RUB) and to assess the ecological and economic impact of the switch. The ecological analysis was based on the life cycle assessment method. Based on 30 operating rooms in a single tertiary university hospital, the economic analysis compared the usual SUB supplier with four RUB suppliers considering different costs: blade purchasing and depreciation, reprocessing, logistics and waste management. In 2021, 17,200 intubations were performed requiring about 147 RUBs. Switching from SUB to RUB led to an annual saving of 26.5 tons of CO In a model of 17,200 intubations /year, switching SUD to RUB would save 26.5 tons of CO

Identifiants

pubmed: 37437711
pii: S2352-5568(23)00084-X
doi: 10.1016/j.accpm.2023.101276
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101276

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Auteurs

N Rouvière (N)

Department of Pharmacy, Nîmes University Hospital, University of Montpellier, Nîmes, France.

S Chkair (S)

Institute Desbrest of Epidemiology and Public Health, INSERM, University Montpellier, Montpellier, France.

F Auger (F)

Primum non nocere agency, Beziers, France.

P Cuvillon (P)

UR-UM103 IMAGINE, University Montpellier, Division of Anesthesia Critical Care, Pain and Emergency Medicine, Montpellier, France.

G Leguelinel-Blache (G)

Department of Pharmacy, Nîmes University Hospital, University of Montpellier, Nîmes, France; Institute Desbrest of Epidemiology and Public Health, INSERM, University Montpellier, Montpellier, France.

V Chasseigne (V)

Department of Pharmacy, Nîmes University Hospital, University of Montpellier, Nîmes, France; Institute Desbrest of Epidemiology and Public Health, INSERM, University Montpellier, Montpellier, France. Electronic address: virginie.chasseigne@chu-nimes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH